High-throughput urine screening platform for early CKD
RAMETRIX is a urine-based screening system for early detection of Chronic Kidney Disease. It shines a laser on a urine sample and uses Raman spectroscopy to read the molecular fingerprint of the fluid, then applies statistical software (chemometrics) to determine whether the sample indicates kidney dysfunction. The system includes a motorized carousel that cycles through many samples automatically, making it suitable for hospital labs or large screening programs. The result is a fast, low-cost, non-invasive test that could catch CKD years before it becomes end-stage disease.
What you could build
A benchtop diagnostic instrument sold or leased to hospital clinical labs, reference laboratories, and public health screening programs that processes high volumes of urine samples for CKD risk — the buyer is the lab director or health system procurement team seeking cost-effective population screening.
Who in Virginia should care
Virginia health systems (Inova, VCU Health, Sentara), the large veteran population served by VA medical centers across the state, and life-sciences commercialization groups in the Northern Virginia and Richmond corridors would be natural early adopters or licensing partners.
Readiness: Prototype likely
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- John L. Robertson, Ryan Senger
- Granted
- April 16, 2024
- Status
- Granted patent
- Patent number
- 11959858
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology.
Prosim summaries are generated from public patent text and are not legal advice.